Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy for Gallbladder Cancer
Launched by HOSPITAL DEL MAR · Sep 25, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background:
The gallbladder is the most common primary cancer site among the biliary tracts and its incidence is increasing. Its prognosis is still poor with a 5-year survival of almost 20%.
Cholecystectomy is curative in patients with Tis and T1a. For patients with resectable T1b and above disease, radical cholecystectomy is advocated consisting of en bloc resection of the gallbladder, wedge resection of the liver or segment 4b, extrahepatic bile duct, and the regional lymph nodes.
Traditionally, the open approach was preferred over laparoscopic approach due to the difficulty in achievi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>T1b gallbladder cancers
- • Age at least 18 years;
- • Types of surgery include Robotic, Laparoscopic and Open approach
- • A statement by each centre will be required confirming the number of procedures - minimum 1 year of follow up
- Exclusion Criteria:
- • - not completed data
About Hospital Del Mar
Hospital del Mar is a leading healthcare institution located in Barcelona, Spain, renowned for its commitment to medical excellence and patient care. As a prominent clinical trial sponsor, Hospital del Mar actively engages in innovative research aimed at advancing medical knowledge and improving therapeutic outcomes across various specialties. The hospital boasts a multidisciplinary team of experienced researchers and healthcare professionals dedicated to conducting rigorous clinical trials in accordance with the highest ethical and regulatory standards. Through collaboration with academic institutions and industry partners, Hospital del Mar strives to translate research findings into tangible benefits for patients, enhancing the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported